{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-12571538-teriparatide:v1","objectPathId":"pubmed-pmid-12571538-teriparatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-12571538-teriparatide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-12571538-teriparatide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-12571538-teriparatide-v1.md"},"story":{"slug":"pubmed-pmid-12571538-teriparatide","version":1,"domain":"Literature metadata","dateInSource":"2013-11-21","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["teriparatide"],"peptides":[{"slug":"teriparatide","url":"https://peptidescanner.com/peptides/teriparatide/"}]},"claims":[{"id":"headline","text":"Teriparatide (forteo) for osteoporsis.","sourceIds":["pubmed-observation-pmid-12571538-2013-11-21-dddce1ceb373"]},{"id":"summary","text":"PubMed lists PMID 12571538 in The Medical letter on drugs and therapeutics as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2003-02-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12571538-2013-11-21-dddce1ceb373"]},{"id":"paragraph-1","text":"PubMed lists PMID 12571538 in The Medical letter on drugs and therapeutics as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2003-02-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12571538-2013-11-21-dddce1ceb373"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-12571538-2013-11-21-dddce1ceb373"]}],"sources":[{"id":"pubmed-observation-pmid-12571538-2013-11-21-dddce1ceb373","name":"PubMed","sourceClass":"A","title":"Teriparatide (forteo) for osteoporsis. · retained source version 1:2013-11-21:current:dddce1ceb37366550dd5994cf5fdf17694c4efe10a1757d3437b12075e4497f7","url":"https://pubmed.ncbi.nlm.nih.gov/12571538/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"19f133e7383e4392f2376cd88e67ed1e79386ba3746f0549c6c9478f7e69810c","tierARecordSha256":"b1d0adc8fbff3ba9fe3130604696f22945a0708c2a48a68e55edfd39ca4839c1"},"integrity":{"algorithm":"sha256","contentSha256":"00abca0123a9a26223cb91c82721188988b1d984f99342a72af4e746a25b0c36"}}